Clidinium

DB00771ApprovedSmall moleculeAnticholinergic Agents

Clidinium is a synthetic anticholinergic used to treat peptic ulcer disease, colicky abdominal pain, diverticulitis, and IBS. Clidinium is a synthetic anticholinergic agent which has been shown in experimental and clinical studies to have a pronounced antispasmodic and antisecretory effect on the gastrointestinal tract.

Chemical structure of Clidinium
Mechanism
Curator reviewed
Primary indication
For the treatment of peptic ulcer disease and also to help relieve abdominal or stomach spasms or cramps due to colicky abdominal pain, diverticulitis, and irritable bowel syndrome.Curator reviewed · 3 structured indications
Formula / weight
C22H26NO3 · 352.4467 g/mol (avg)
First approval
Canada, 1998 · United States, 1966
Brand names
  • Chlorax
  • Librax

Resolves to

Compound
UNIIBO76JF850NCAS7020-55-5ChEBI3743PubChem2784KEGGC07853
Clinical / RWD
RxNorm21232ATCA03CA02PharmGKBPA164781044
Structure
InChIKeyHOOSGZJRQIVJSZ-NNBUQUNQSA-NSMILESC[N@@+]12CC[C@@H](CC1)C(C2)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1
Targets
P20309CHRM3P11229CHRM1

What you can answer from here — as of September 23, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
984Drug interactionsStructured to mechanism, not free text
Sign in
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
3ContraindicationsEach with its own population and attribute set
Sign in
72Marketed productsAcross 7 countries and 50 labellers
Sign in
1ATC codeIncluding every combination product, plus 18 drug categories
Sign in
7+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Clidinium, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In